LifeGuide

Hep Talk Hepatitis C Antiviral Telaprevir Moves Closer to Approval by Larry Buhl Researchers in a recent Phase III study are encouraged by the results of a...

The HealtheVoices Conference, a three-day event that brings together online advocates from across various health conditions, including HIV/AIDS, provides valuable content, such as tips...

HIV-related diarrhea is a damaging condition that can greatly affect quality of life, as well as increase the risk of mortality in people living...

What’s Your Damage?” was the name of the arts panel that kicked off the opening night of ACT UP/San Francisco’s reunion gathering commemorating the...

By the Numbers While HCV prevalence is down, the rate of morbidity may be going up by Larry Buhl New data on the prevalence of hepatitis C...

Therapeutic Vaccine Research Toward a Functional Cure Shows Promise by Jeannie Wraight Until recently, therapeutic vaccines and immune-based therapies (IBTs) were all but shunned by the...

What were the top five HCV-related stories of 2012? by Larry Buhl There were many important news stories about hepatitis in 2012. In this column we...

AIDS Healthcare Foundation Trains a Research Lens on Probiotics by Chael Needle "Probiotics” has become a new buzz word in the dairy aisle—at least two brands...

It’s a state with a relatively low prevalence of HIV, but a high number of convictions for HIV non-disclosure and some of the nation’s...

Race to the Cure Who are the biggest players now in eradicating hepatitis C? by Larry Buhl Beyond the implementation of the Affordable Care Act, one of...